Background: COVID changed healthcare modalities and we found out that needed services were not met for diabetic patients. Continuous glucose monitoring (CGM) has been a technology used for Type 1 diabetic patients for years. With the rising numbers of both Type 2 diabetic (T2DM) and prediabetic patients, expanding the use of this technology could be beneficial in this population.

Methodology: A review of nursing and medical literature was completed using search engines from the Simmons library, CINAHL, Medline databases, and Google Scholar. The key terms that were used in combinations were Diabetes Mellitus Type 2, T2DM, Prediabetes, Continuous Glucose Monitor, CGM, benefits/advantages, prevention, nursing, and challenges. This is a rapid review of the literature.

Findings: After reviewing the literature, three themes emerged including findings that indicated that the use of CGM is an important tool for prediabetic and T2DM patients; as lifestyles changed, HbA1C results lowered, and these patients had less hypoglycemic episodes.